The incidence of
Alzheimer’s and other forms of dementia is growing rapidly throughout the world.
There is a critical need for a technology that enables early diagnosis
economically and that can also accurately measure the effectiveness of
treatments for these diseases. Research has now demonstrated that analysis of the
P300 brainwave can show dementia onset and progression. MERMER technology,
developed and patented by Brain Fingerprinting Laboratories, includes the P300
brainwave and extends it, providing a more sensitive measure than the P300
alone. Brain Fingerprinting Laboratories is now developing diagnostic and
monitoring systems for Alzheimer’s using this exciting new
technology.
